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Abstract: 
 
Background: Clinicians have recognised the role of narrow band imaging (NBI) in the management of 
head and neck cancer in several studies. However, a recent systematic review was unable to pool 
the data on diagnostic efficacy in this setting owing to the heterogeneity in the published data. 
Methods ?^ĞĐŽŶĚĂƌǇĂŶĂůǇƐŝƐŽĨĚĂƚĂ ?ƵƚŝůŝƐŝŶŐĂǇĞƐ ?ƚŚĞŽƌĞŵ ?ĨƌŽŵŵĞƚĂ-analyses and randomised 
trials 
Results: In patients with a histological diagnosis of mild dysplasia who show no abnormalities on NBI, 
the post-test probability of malignancy is 2.3%, compared to 10.3% with conventional white light 
imaging (WLI). For severe dysplasia, similar post-test probabilities after NBI and WLI are 8.0% and 
29.7% respectively. Post-test probabilities in this setting indicate the chance of missing malignancy 
following a negative NBI or WLI in patients who undergo no further intervention. This paper also 
provides a nomogram designed for use in this setting. 
Conclusions: This paper identifies the evidence base for use of NBI in the follow up for laryngeal  
dysplasia. 
 
Introduction  
The management of laryngeal dysplasia has historically been subject to significant variation, and 
practice was largely based on personal and institutional policies 
1
.  However, ENT UK has led on the 
formulation of multispecialty consensus management guidelines for laryngeal dysplasia, based on 
robust analysis of published data and professional opinion prevalent in 2010 
2
.  This has helped to 
streamline the provision of laryngeal dysplasia services 
3
.  
Diagnosis is established by tissue biopsy and follow up is needed for high risk patients. The 
consensus guidelines recommend flexible nasolaryngoscopy and colour photo-documentation as a 
minimum follow up as standard. Change in the appearance of the dysplastic lesions is usually a 
trigger for a biopsy, and accurate photo documentation of the lesion enables such change to be 
detected.   
The authors recently performed systematic review to pool published data on the diagnostic efficacy 
of narrow band imaging (NBI) within head and neck practice 
4
.  Although the available data 
pertaining to laryngeal dysplasia could not be pooled due to significant heterogeneity and was 
presented in a descriptive fashion, a careful assessment, re-analysis and re-interpretation of the 
published data, in conjunction with pooled data on malignant transformation rates published earlier 
5
, suggests an important role that NBI that can play in patient follow up. We present an 
interpretation of data based on further analysis of two studies using Bayes ? theorem.  
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Ethical considerations: 
Being a secondary analysis of published data, no ethical considerations arise in this study. 
Studies used in the analysis:  
A systematic review on the role of NBI in dysplastic lesions 
4
 identified the study by Muto et al 
6
 as 
the only randomised controlled study in the literature that uses NBI in the diagnostic setting, 
comparing the detection rate for superficial squamous cell carcinoma in the head and neck region 
using NBI with conventional white light imaging (WLI).  The study enrolled 333 patients with 
histologically confirmed oesophageal squamous cell carcinoma, aged 20 years or older, newly 
diagnosed or on follow up. As this patient group has a high prevalence of synchronous or 
metachronous malignancies, the upper aerodigestive tract (UADT) mucosa was assessed during 
oesophagoscopy. Patients were randomised to primary WLI followed by NBI, performed back to 
back at the same sitting, or primary NBI followed by WLI. The primary outcome was to identify 
lesions that that appeared as slightly elevated lesions lower than 5 mm, flat lesions, and lesions with 
a shallow depression that were later histologically proven to be carcinoma in situ or microinvasive 
squamous cell carcinoma (SCC). These were characterised by a well demarcated brownish area with 
irregular microvascular patterns. Overt lesions with an elevation greater than 5mm or those with 
apparent deeper ulceration were not evaluated. 
Of the 333 patients enrolled, 13 were excluded and the analysis included 320 randomly allocated 
patients. In the primary WLI group (n=162), one of 13 superficial squamous cell cancer was detected 
in the UADT mucosa, compared with 15 detected in 15 patients in the primary NBI group. This 
difference was statistically significant (p< 0.01).  This paper reported in detail the diagnostic accuracy 
of WLI and NBI, shown in Table 1.  
Weller et al 
5
 reported a systematic review of observational studies on laryngeal dysplasia and 
pooled selected data as a meta-analysis, one aspect of which focused on the malignant 
transformation rates (MTR). The data from nine studies including 940 cases suggested that overall 
malignant transformation rate was 14% (95%CI: 8%, 22%); the malignant transformation rate was 
higher with severe dysplasia/carcinoma in situ (30.4%) compared to mild/moderate (10.6%) (p< 
0.0002).  
 
Secondary analysis and interpretation of the above data:  
Further analysis, utilising ĂǇĞƐ ?ƚŚĞŽƌĞŵ, allows the post-test probability of disease to be calculated 
by combining the pre-test probability with the likelihood ratio for the test 
7
.  A pre-test probability 
for mild/moderate dysplasia is estimated as 10.6% (95% CI: 5.1 ?20.7) and for severe dysplasia as 
30.4% (95% CI: 16.1 ?49.9) from Weller et al 5 . 
The negative likelihood ratio (-LR), the probability of testing negative with disease compared to the 
probability testing negative when not, can be calculated using estimates of sensitivity and specificity 
from the test. Estimates of sensitivity and specificity for WLI and NBI (Table 1) are taken from the 
Muto et al trial 
6
. The -LRs with associated 95% confidence intervals (calculated using the 
bootstrapping method of Marill et al 
8
) are 0.97 (0.70 - 1.00) and 0.00 (0.00 - 0.20) for WLI and NBI 
respectively. When the -LR is <0.1 (as is the case with the point estimate for NBI), it can be 
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interpreted as a large and often conclusive decrease in likelihood of disease. However, when the -LR 
is 0.5  ? 1 (as is the case with WLI) only minimal decrease in likelihood of disease can be expected.  
Thus, if follow up assessment using NBI does not have findings suggestive of superficial cancer as per 
the description above, the clinician can have confidence that the lesion has not undergone 
malignant transformation.   
The pre-test probability can be combined with the -LR of the test, using BayeƐ ?ƚŚĞŽƌĞŵ ? to obtain a 
post-test probability of malignancy. The calculation proceeds by first converting the pre-test 
probability to pre-test odds, multiplying by the  ?LR, then converting the post-test odds to a post-test 
ƉƌŽďĂďŝůŝƚǇ ?dŚĞƐĞĐĂůĐƵůĂƚŝŽŶƐĐŽƵůĚĂůƐŽďĞƐŚŽǁŶŽŶĂĂǇĞƐ ?ŶŽŵŽŐƌĂŵ7 ?ĂĚĂƉƚĞĚĨƌŽŵ&ĂŐĂŶ ?Ɛ
nomogram 
9, 10
.  
Given that the sample -LR for NBI is zero, the upper bound of the 95% confidence interval (0.00 - 
0.20) is used in place of the point estimate in subsequent calculations. This is a conservative choice 
and follows the advice of Marill et al 
8
, who suggest that the upper bound is the critical metric to use 
when evaluating a diagnostic test in this scenario. For WLI, the point estimate of the -LR of 0.97 is 
used in subsequent calculations, this estimate is very close to the upper bound of the 95% 
confidence interval (0.70 - 1.00).   
Let us consider a patient who has a histological diagnosis of mild dysplasia who is under follow up 
with a pre-test probability of malignancy of 10.6%.  An NBI with no abnormalities gives the post-test 
probability of malignancy to be 2.3%. The interpretation for a negative NBI in this setting is thus: the 
probability of testing negative for a malignancy, and thus missing a diagnosis if no intervention were 
to be performed on this basis is 2.3%, an acceptable margin of error. Using WLI, the post-test 
probability of missing a malignancy is 10.3%. This margin of error would be unacceptable in most 
clinical situations.  
Let us now assume a patient with a histological diagnosis of severe dysplasia with a pre-test 
probability of 30.4%. The post-test probability, and thus the chance of missing malignancy in a 
patient with severe dysplasia who has a negative result from NBI and undergoes no further 
intervention on the basis of this test is 8.0%.  For WLI, the post-test probability and the chance of 
missing malignancy is 29.7%. These figures would be considered too high in clinical practice. Other 
pre-test probabilities, for example based on local population data, can be used to work out post-test 
probabilities, as illustrated in Figure 1.  
 
Discussion: 
As recent literature review has not shown a clear way forward, and prospective studies on this 
specific group are awaited, we elected to perform this secondary analysis to make the best use of 
available data. Our findings suggest that NBI could play a significant role in follow up of patients with 
laryngeal dysplasia. Across all histological grades of dysplasia, WLI has greater chance of missing 
malignant transformation during follow-up compared with NBI. For patients with mild laryngeal 
dysplasia, the point estimate and the upper limit of confidence interval for the -LR are both low 
enough to consider a non-intervention policy based on the clinical findings.  However, for patients 
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with severe dysplasia, greater caution should be exercised, although the clinician is four times less 
likely to miss malignant transformation when NBI is used for follow up.  
Strengths and weaknesses of the analysis:  
Although the Muto et al 
6
 paper included all UADT mucosal sites, and did not present data on 
laryngeal sites separately, the patient selection with appropriate risk factors and the exclusion of 
previously radiated patients make for a reasonably comparable group. The median age for the 
population was 64, with alcohol use reported in over 94% of patients and 90% being smokers. 
Recent papers 
11
 provide further data on the diagnostic efficacy rates of NBI in laryngeal precancer 
that are similar to the figures identified in the study by Muto et al 
6
.  Clinically, the interpretation of 
NBI for laryngeal and other mucosal sites remain uniform; thus, we do not have major concerns with 
the applicability of this data to the laryngeal dysplasia population. However, the study was 
performed on a Japanese population and we recommend that the reader carefully peruse the data 
in this trial. It is the publication of the robust MTR that allows us to be confident in our 
recommendation. Indirect proof of this recommendation can also be found in studies that use NBI to 
define superficial resection margins during transoral laser surgery for early laryngeal cancers 
12
; the 
positive margin rate drops significantly (3.6% vs 23.7%) when the mucosal cuts are performed using 
NBI than with WLI.  Similarly, Staníková et al 
13
 identified close concordance between NBI endoscopy 
findings are histological evidence malignant transformation (kappa index 0.77, p < 0.001) in their 
ƉƌŽƐƉĞĐƚŝǀĞĐŽŚŽƌƚŽĨ ? ?ƉĂƚŝĞŶƚƐ ?ƚŚĞǇĐŽŶĐůƵĚĞŝŶƚŚĞŝƌƐƚƵĚǇƚŚĂƚĂ “ŶĞŐĂƚŝǀĞE/ĞŶĚŽƐĐŽƉǇŵĂǇ
be an indication for long-term endoscopy follow-ƵƉǁŝƚŚŽƵƚŚŝƐƚŽůŽŐŝĐĂůĞǀĂůƵĂƚŝŽŶ ? ? 
We acknowledge the variability in the sensitivity and specificity estimates used to derive the 
likelihood ratio due to the small number of cancers observed in the Muto study. As such, it is 
recommend that further confirmation of the conclusions of this re-analysis be sought in the real 
world from clinical trials.  A major caveat is the thick keratotic lesion that prevents assessment of the 
submucosal vessels, negating the added value of NBI.   
Clinical applicability of the data:  
In a retrospective analysis of laryngeal biopsies performed in North Glasgow, Scotland, between 
2001 and 2010, Lim et al 
14
 showed that there has been a significant increase in the number of 
biopsies performed from 2005; Between 2004 and 2005, the number of biopsies in the dysplasia 
category increased by 20%, with the increasing number primarily in the severe dysplasia and 
carcinoma in situ category (p<0.001). It is widely recognised that repeated laryngeal biopsies can 
have an adverse effect on the voice outcomes.  Based on this analysis, we believe that a negative NBI 
test should allow more confident outpatient management of patients on follow up for laryngeal 
dysplasia, and avoid general anaesthetic and biopsy. This analysis also supports the need for a 
prospective trial in this setting.  
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